Clinical Trial Update: Symbiot III: A Prospective Randomized Trial Evaluating the Symbiot Covered Stent System in Saphenous Vein Grafts [NA]

View source ↗

Summary

This document reports the completion of the Symbiot III trial, a prospective randomized study evaluating the Symbiot covered stent system in saphenous vein graf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemic Heart Disease
• Saphenous Vein Graft Disease

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Symptomatic Ischemic Saphenous Vein Graft Disease | NA | Status: COMPLETED